Literature DB >> 9353058

Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock.

F Mattner1, L Ozmen, F J Podlaski, V L Wilkinson, D H Presky, M K Gately, G Alber.   

Abstract

The role of interleukin-12 (IL-12) was investigated in different shock models using anti-IL-12 reagents. IL-12 is composed of two disulfide-bonded subunits, p35 and p40. The IL-12 p40 homodimer (p40)2 has been shown to be a potent IL-12 antagonist in vitro. We investigated its in vivo inhibitory capacity in different shock models of mice. We could demonstrate that (p40)2 is able to protect mice from septic shock in primarily IL-12-dependent models such as the Shwartzman reaction and lipopolysaccharide (LPS)-induced shock, whereas (p40)2 has no effect in the tumor necrosis factor alpha-dependent LPS/D-GalN shock model. In IL-12-dependent shock models, (p40)2 inhibits IL-12-induced gamma interferon production and thereby interferes with the cascade of cytokine release, finally leading to death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353058      PMCID: PMC175679          DOI: 10.1128/iai.65.11.4734-4737.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Characterization of anti-mouse IL-12 monoclonal antibodies and measurement of mouse IL-12 by ELISA.

Authors:  V L Wilkinson; R R Warrier; T P Truitt; P Nunes; M K Gately; D H Presky
Journal:  J Immunol Methods       Date:  1996-01-16       Impact factor: 2.303

2.  Cloning of a new cytokine that induces IFN-gamma production by T cells.

Authors:  H Okamura; H Tsutsi; T Komatsu; M Yutsudo; A Hakura; T Tanimoto; K Torigoe; T Okura; Y Nukada; K Hattori
Journal:  Nature       Date:  1995-11-02       Impact factor: 49.962

3.  Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.

Authors:  M Wysocka; M Kubin; L Q Vieira; L Ozmen; G Garotta; P Scott; G Trinchieri
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

4.  The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer.

Authors:  F Mattner; S Fischer; S Guckes; S Jin; H Kaulen; E Schmitt; E Rüde; T Germann
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

5.  Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon.

Authors:  F P Heinzel; R M Rerko; P Ling; J Hakimi; D S Schoenhaut
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

Authors:  K Pfeffer; T Matsuyama; T M Kündig; A Wakeham; K Kishihara; A Shahinian; K Wiegmann; P S Ohashi; M Krönke; T W Mak
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

7.  Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist.

Authors:  S Gillessen; D Carvajal; P Ling; F J Podlaski; D L Stremlo; P C Familletti; U Gubler; D H Presky; A S Stern; M K Gately
Journal:  Eur J Immunol       Date:  1995-01       Impact factor: 5.532

8.  Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.

Authors:  G M Doherty; J R Lange; H N Langstein; H R Alexander; C M Buresh; J A Norton
Journal:  J Immunol       Date:  1992-09-01       Impact factor: 5.422

9.  Interferon gamma receptor deficient mice are resistant to endotoxic shock.

Authors:  B D Car; V M Eng; B Schnyder; L Ozmen; S Huang; P Gallay; D Heumann; M Aguet; B Ryffel
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

10.  Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction.

Authors:  L Ozmen; M Pericin; J Hakimi; R A Chizzonite; M Wysocka; G Trinchieri; M Gately; G Garotta
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  24 in total

Review 1.  IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses.

Authors:  G Haskó; C Szabó
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1.

Authors:  Sabine Vollstedt; Susi Arnold; Cornelia Schwerdel; Marco Franchini; Gottfried Alber; James P Di Santo; Mathias Ackermann; Mark Suter
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14.

Authors:  F Nicoletti; R Di Marco; P Sacerdote; P Meroni; K Mangano; C Edwards; A Bartorelli; K Bendtzen; A Panerai
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.

Authors:  S Vollstedt; M Franchini; G Alber; M Ackermann; M Suter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection.

Authors:  Yaming Wang; Melissa Swiecki; Marina Cella; Gottfried Alber; Robert D Schreiber; Susan Gilfillan; Marco Colonna
Journal:  Cell Host Microbe       Date:  2012-06-14       Impact factor: 21.023

6.  Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin.

Authors:  F N Lauw; T ten Hove; P E Dekkers; E de Jonge; S J van Deventer; T van Der Poll
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 7.  The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases.

Authors:  Christoph Hölscher
Journal:  Med Microbiol Immunol       Date:  2003-06-27       Impact factor: 3.402

8.  Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.

Authors:  Mollie Jurewicz; Sunmi Yang; Andrea Augello; Jonathan G Godwin; Robert F Moore; Jamil Azzi; Paolo Fiorina; Mark Atkinson; Mohamed H Sayegh; Reza Abdi
Journal:  Diabetes       Date:  2010-09-14       Impact factor: 9.461

9.  Arid5a exacerbates IFN-γ-mediated septic shock by stabilizing T-bet mRNA.

Authors:  Mohammad Mahabub-Uz Zaman; Kazuya Masuda; Kishan Kumar Nyati; Praveen Kumar Dubey; Barry Ripley; Kai Wang; Jaya Prakash Chalise; Mitsuru Higa; Hamza Hanieh; Tadamitsu Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

10.  Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans.

Authors:  K Decken; G Köhler; K Palmer-Lehmann; A Wunderlin; F Mattner; J Magram; M K Gately; G Alber
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.